NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients
NCT06131424
·
clinicaltrials.gov ↗
COMPLETED
Status
1151
Enrollment
INDUSTRY
Sponsor class
Conditions
HER2-negative
Sponsor
AstraZeneca